140 related articles for article (PubMed ID: 26927666)
21. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
22. Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients.
Takenaka T; Yano T; Kiyohara C; Miura N; Kouso H; Ohba T; Kometani T; Shoji F; Yoshino I; Maehara Y
Lung Cancer; 2010 Jan; 67(1):101-7. PubMed ID: 19361884
[TBL] [Abstract][Full Text] [Related]
23. Circadian regulation gene polymorphisms are associated with sleep disruption and duration, and circadian phase and rhythm in adults with HIV.
Lee KA; Gay C; Byun E; Lerdal A; Pullinger CR; Aouizerat BE
Chronobiol Int; 2015; 32(9):1278-93. PubMed ID: 26512752
[TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
[TBL] [Abstract][Full Text] [Related]
25. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence.
Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034
[TBL] [Abstract][Full Text] [Related]
26. Variations in circadian genes and individual nocturnal symptoms of insomnia. The HUNT study.
Bragantini D; Sivertsen B; Gehrman P; Lydersen S; Güzey IC
Chronobiol Int; 2019 May; 36(5):681-688. PubMed ID: 30862195
[TBL] [Abstract][Full Text] [Related]
27. Association between Promoter Polymorphisms of TFF1, TFF2, and TFF3 and the Risk of Gastric and Diffuse Gastric Cancers in a Korean Population.
Jin EH; Lee SI; Kim J; Seo EY; Lee SY; Hur GM; Shin S; Hong JH
J Korean Med Sci; 2015 Aug; 30(8):1035-41. PubMed ID: 26240479
[TBL] [Abstract][Full Text] [Related]
28. Polymorphism of circadian clock genes and prophylactic lithium response.
Rybakowski JK; Dmitrzak-Weglar M; Kliwicki S; Hauser J
Bipolar Disord; 2014 Mar; 16(2):151-8. PubMed ID: 24636202
[TBL] [Abstract][Full Text] [Related]
29. DNA methyltransferase 3a rs1550117 genetic polymorphism predicts poor survival in gastric cancer patients.
Wang C; Jia Z; Ma H; Cao D; Wu X; Wen S; You L; Cao X; Jiang J
Int J Clin Exp Pathol; 2015; 8(11):14864-74. PubMed ID: 26823816
[TBL] [Abstract][Full Text] [Related]
30. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
31. Association of nucleotide excision repair pathway gene polymorphisms with gastric cancer and atrophic gastritis risks.
Liu J; Sun L; Xu Q; Tu H; He C; Xing C; Yuan Y
Oncotarget; 2016 Feb; 7(6):6972-83. PubMed ID: 26760766
[TBL] [Abstract][Full Text] [Related]
32. Tag SNPs in long non-coding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population.
Yang C; Tang R; Ma X; Wang Y; Luo D; Xu Z; Zhu Y; Yang L
Oncotarget; 2015 Jun; 6(17):15311-20. PubMed ID: 25944697
[TBL] [Abstract][Full Text] [Related]
33. Polymorphism in one-carbon metabolism pathway affects survival of gastric cancer patients: Large and comprehensive study.
Zhao T; Gu D; Xu Z; Huo X; Shen L; Wang C; Tang Y; Wu P; He J; Gong W; He ML; Chen J
Oncotarget; 2015 Apr; 6(11):9564-76. PubMed ID: 25840420
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
35. Association of the miR-146a rs2910164 polymorphism with gastric cancer susceptibility and prognosis.
Jiang J; Jia ZF; Cao DH; Wu YH; Sun ZW; Cao XY
Future Oncol; 2016 Oct; 12(19):2215-26. PubMed ID: 27267319
[TBL] [Abstract][Full Text] [Related]
36. Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population.
Lin X; Hu D; Chen G; Shi Y; Zhang H; Wang X; Guo X; Lu L; Black D; Zheng XW; Luo X
Cancer Genet; 2016 May; 209(5):215-22. PubMed ID: 27160021
[TBL] [Abstract][Full Text] [Related]
37. Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy.
Grau JJ; Caballero M; Monzó M; Muñoz-García C; Domingo-Domenech J; Navarro A; Conill C; Campayo M; Bombí JA
J Surg Oncol; 2008 Aug; 98(2):130-4. PubMed ID: 18537153
[TBL] [Abstract][Full Text] [Related]
38. Association between GWAS-identified genetic variations and disease prognosis for patients with colorectal cancer.
Kang BW; Jeon HS; Chae YS; Lee SJ; Park JY; Choi JE; Park JS; Choi GS; Kim JG
PLoS One; 2015; 10(3):e0119649. PubMed ID: 25799222
[TBL] [Abstract][Full Text] [Related]
39. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.
Liu B; Wei J; Zou Z; Qian X; Nakamura T; Zhang W; Ding Y; Feng J; Yu L
Eur J Hum Genet; 2007 Oct; 15(10):1049-53. PubMed ID: 17593927
[TBL] [Abstract][Full Text] [Related]
40. Functional polymorphisms of ATP citrate lyase gene predicts clinical outcome of patients with advanced colorectal cancer.
Xie S; Zhou F; Wang J; Cao H; Chen Y; Liu X; Zhang Z; Dai J; He X
World J Surg Oncol; 2015 Feb; 13():42. PubMed ID: 25890184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
